The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004

Preventive Medicine

Volumn 49, Issue 1, 2009, Pages 68-73

  Holtzman, Deborah ^a   Barry, Vaughn ^a   Ouellet, Lawrence J ^b   Jarlais, Don C Des ^c   Vlahov, David ^d   Golub, Elizabeth T ^e   Hudson, Sharon M ^f   Garfein, Richard S ^g  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d NEW YORK ACADEMY OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug injection risk behaviors; Hepatitis C virus infection; Injection drug use; Injection drug users (IDUs); Needle exchange programs; Surveys; United States; Young adults

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH SURVEY; HEPATITIS C; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROPREVALENCE; UNITED STATES;

ADOLESCENT; ADULT; DRUG USERS; FEMALE; HARM REDUCTION; HEPATITIS C; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; URBAN HEALTH; YOUNG ADULT;

EID: 67650996489     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.04.014     Document Type: Article

References (47)

1. Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144 10 (2006) 705-714
2. Bailey S.L., Huo D., Garfein R.S., et al. The use of needle exchange by young injection drug users. J. Acquir. Immune Defic. Syndr. 34 1 (2003) 67-70
3. Bluthenthal R.N., Kral A.H., Gee L., et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 14 (2000) 605-611
4. Burt R.D., Hagan H., Garfein R.S., et al. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J. Urban Health 84 3 (2007) 436-454
5. Crofts N., Nigro L., Oman K., et al. Methodone maintenance and hepatitis C virus infection among injecting drug users. Addiction 92 (1997) 999-1005
6. Diaz T., Des Jarlais D.C., Vlahov D., et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am. J. Public Health 91 (2001) 23-30
7. Estrada A.L. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep. 117 (2002) S126-S134
8. Garfein R.S., Doherty M.C., Monterroso E.R., et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 Suppl. 1 (1998) S11-S19
9. Garfein R.S., Swartzendruber A., Ouellet L.J., et al. Methods to recruit and retain a cohort of young-adult injection drug users for the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT). Drug Alcohol. Depend. 91 (2007) S4-S17
10. Gibson D.R., Flynn N.M., and Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15 (2001) 1329-1341
11. Golub E.T., Strathdee S.A., Bailey S.L., et al. Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol. Depend. 91 (2007) S30-S38
12. Hagan H., and Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J. Urban Health 77 (2000) 369-382
13. Hagan H., Des Jarlais D.C., Friedman S.R., et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am. J. Public Health 85 (1995) 1531-1537
14. Hagan H., McGough J.P., Thiede H., et al. Syringe exchange and risk of infection with hepatitis B and C viruses. Am. J. Epidemiol. 149 3 (1999) 203-213
15. Hagan H., Weiss N.S., Thiede H., et al. Reply to "Invited Commentary: Needle exchange-no help for hepatitis?" by Moss and Hahn. Am. J. Epidemiol. 149 3 (1999) 217-218
16. Hagan H., Thiede H., Weiss N.S., et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
17. Hagan H., Campbell J.V., Thiede H., et al. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol. Depend. 91 (2007) S48-S55
18. Hahn J.A., Vranizan K.M., and Moss A.R. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. JAIDS 15 (1997) 157-164
19. Hahn J.A., Page-Shafer K., Lum P.J., et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 34 1 (2001) 180-187
20. Hahn J.A., Page-Shafer K., Lum P.J., et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J. Infect. Dis. 186 (2002) 1558-1564
21. Hart G.J., Carvell A.L.M., Woodward N., et al. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. AIDS 3 (1989) 261-265
22. Huo D., and Ouellet L.J. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. J. Acquir. Immune Defic. Syndr. 45 1 (2007) 108-114
23. Hurley S.F., Jolley D.J., and Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349 (1997) 1797-1800
24. Kapadia F., Vlahov D., Des Jarlais D.C., et al. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?. Epidemiology 13 (2002) 738-741
25. Latka M., Ahern J., Garfein R.S., et al. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J. Subst. Abuse 13 (2001) 73-88
26. Macalino G.E., Celentano D.D., Latkin C., et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ. Prev. 14 (2002) 367-378
27. Monterroso E.R., Hamburger M.E., Vlahov D., et al. Prevention of HIV infection in street-recruited injection drug users. JAIDS 25 (2000) 63-70
28. National Institutes of Health. Management of hepatitis C: 2002. NIH Consens. Statement. 19 (2002) 1-46
29. Nicolosi A., Lea Correa Leite M., Musicco M., et al. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am. J. Epidemiol. 135 3 (1992) 225-233
30. Ouellet L.J., Huo D., and Bailey S.L. HIV risk practices among needle exchange users and nonusers in Chicago. J. Acquir. Immune Defic. Syndr. 37 1 (2004) 1187-1196
31. Perlis T.E., Des Jarlais D.C., Friedman S., et al. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction 99 7 (1999) 885-896
32. Rezza G., Sagliocca L., Zaccarelli M., et al. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand. J. Infect. Dis. 28 (1996) 27-29
33. Rustgi V.K. The epidemiology of hepatitis C infection in the United States. J. Gastroenterol. 42 (2007) 513-521
34. Safaeian M., Brookmeyer R., Vlahov D., et al. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am. J. Epidemiol. 155 2 (2002) 169-175
35. Santibanez S.S., Garfein R.S., Swartzendruber A., et al. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol. Depend. 77 (2005) 227-233
36. Selvey L.A., Denton M., and Plant A.J. Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. Aust. N. Z. J. Public Health 21 1 (1997) 102-104
37. Thiede H., Hagan H., and Murrill C.S. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J. Urban Health 77 (2000) 331-345
38. Thomas D.L., Vlahov D., Solomon L., et al. Correlates of hepatitis C virus infections among injection drug users. Medicine 74 (1995) 212-220
39. Thorpe L.E., Ouellet L.J., Hershow R., et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 155 (2002) 645-653
40. Todd C.S., Abed A.M.S., Strathdee S.A., et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg. Infect. Dis. 13 9 (2007) 1327-1331
41. Van den Hoek J.A.R., Van Haastrecht H.J.A., Goudsmit J., et al. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J. Infect. Dis. 162 (1990) 823-826
42. Vlahov D., Junge B., Brookmeyer R., et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. JAIDS 16 (1997) 400-406
43. Wasley A., Grytdal S., and Gallagher K. Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis-United States, 2006. Morb. Mort. Wkly. Rep. 57 (2008) SS2-SS24
44. Watters J.K., Estilo M.J., Clark G.L., et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 271 (1994) 115-120
45. White B., Day C., and Maher L. Self reported risk behaviour among injecting drug users: self versus assisted questionnaire completion. AIDS Care 19 3 (2007) 441-447
46. Wodak A., and Cooney A. Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users (2005), World Health Organization, Geneva
47. Wright N.M.J., and Tompkins C.N.E. A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users. Harm. Reduct. J. 3 (2006) 27-35